Point-Of-Care Molecular Diagnostics Market Future Trends Influencing Growth Through 2030
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Is The Market Size Of The Point-Of-Care Molecular Diagnostics Market Expected To Scale Between 2026 And 2030?
The point-of-care molecular diagnostics market size has demonstrated rapid expansion in recent years. This market is expected to increase from $3.98 billion in 2025 to $4.58 billion in 2026, achieving a compound annual growth rate (CAGR) of 15.0%. Key factors contributing to its historical growth include the rising prevalence of infectious diseases, the broadening of emergency diagnostic testing, an increasing demand for rapid clinical decision support, enhancements in molecular assay technologies, and the expanding application of POC diagnostics in hospitals.
The point-of-care molecular diagnostics market is projected for significant expansion over the coming years. This market is anticipated to reach a valuation of $7.91 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 14.7%. This expansion during the projection period stems from several factors, including the rising uptake of home-based molecular testing, greater investments in swift diagnostic infrastructure, broadening applications for respiratory and oncology testing, the increasing incorporation of cloud-based diagnostic platforms, and a heightened emphasis on detecting diseases early. Key developments anticipated within this timeframe involve the wider acceptance of rapid molecular testing platforms, an escalating need for decentralized diagnostic options, the increasing integration of automated sample processing, the broadening of syndromic testing panels, and a stronger emphasis on achieving quick turnaround times.
Access Your Free Sample Report For In-Depth Market Analysis:
Which Factors Are Influencing The Growth Of The Point-Of-Care Molecular Diagnostics Market?
The increasing occurrence of infectious and respiratory diseases is projected to be a significant contributor to the expansion of the point-of-care molecular diagnostics market. Respiratory infections, caused by microorganisms such as viruses or bacteria, affect the respiratory system. These microbes can spread through coughing, sneezing, or direct contact. Managing respiratory conditions effectively often involves various treatments like inhalers, oral medications, intravenous therapies, and point-of-care molecular diagnostic tools to facilitate patient recovery. For instance, in June 2024, the UK Health Security Agency, a UK-based government agency, reported that between week 40 of 2022 and week 15 of 2023, 108 NHS trusts in England recorded 1,681 critical care admissions for confirmed influenza. In contrast, the previous season saw 182 admissions across 114 trusts, which increased to 316 by week 39 of 2022. Thus, the swift rise in infectious and respiratory diseases and associated fatalities will propel the point-of-care molecular diagnostics market.
How Is The Point-Of-Care Molecular Diagnostics Market Categorized Across Its Segment Groups?
The point-of-care molecular diagnostics market covered in this report is segmented –
1) By Product: Assays And Kits, Instruments And Analyzers
2) By Application: Respiratory Infections, Gastrointestinal Infections, Sexually Transmitted Infections (STIs), Hospital-Acquired Infections (HAIs), Bloodstream and Sepsis-Related Infections
3) By End-User: Decentralized Labs, Hospitals, Home Care, Assisted Living Healthcare Facilities
Subsegments:
1) By Assays And Kits: Nucleic Acid Amplification Tests (NAATs), Rapid Diagnostic Tests, Molecular Detection Kits, Reagents And Consumables
2) By Instruments And Analyzers: Microfluidic Devices, Point-of-Care Analyzers
Which Trends Are Influencing Demand In The Point-Of-Care Molecular Diagnostics Market?
Leading companies within the point-of-care molecular diagnostics market are dedicated to delivering technologically advanced solutions to fortify their market standing. These entities are deploying next-generation point-of-care molecular diagnostics technologies and related services, such as enzyme-linked immunosorbent assay (ELISA), polymerase chain reaction (PCR), mass spectrometry (MS), situ hybridizations, spectral karyotyping imaging, and DNA microarrays, among others. These advancements are implemented on POC devices to accelerate analysis times and lower costs. For instance, in May 2023, Sensible Diagnostics, a US-based diagnostics company, introduced a 10-minute point-of-care PCR system. Sensible Diagnostics is drawing upon the experience Curative gained from its diagnostics business throughout the pandemic. The firm stated it has conducted more than two million molecular point-of-care COVID-19 tests, and its PCR platform achieves a 10-minute time-to-result.
Which Firms Are Influencing Competition In The Point-Of-Care Molecular Diagnostics Market?
Major companies operating in the point-of-care molecular diagnostics market are Abbott Laboratories, F Hoffmann La Roche Ltd, BioMérieux SA, Hologic Inc, Becton Dickinson and Company, Siemens Healthineers AG, QuidelOrtho Corporation, Bio Rad Laboratories Inc, Qiagen N V, Biocartis Group NV, DiaSorin S p A, SD Biosensor Inc, Cue Health Inc, Visby Medical Inc, Binx Health Inc, Molbio Diagnostics Pvt Ltd, Credo Diagnostics Biomedical Pvt Ltd, Genetron Health, Mammoth Biosciences Inc, Seegene Inc
Get The Full Point-Of-Care Molecular Diagnostics Market Report:
Which Region Is The Top Contributor To The Point-Of-Care Molecular Diagnostics Market By Share?
North America was the largest region in the point-of-care molecular diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point-of-care molecular diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Point-Of-Care Molecular Diagnostics Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Point-Of-Care Molecular Diagnostics Market 2026, By The Business Research Company
Molecular Diagnostics Devices And Equipment Market Report 2026
Point Of Care Diagnostics Market Report 2026
https://www.thebusinessresearchcompany.com/report/point-of-care-diagnostics-global-market-report
Biomarker Clinical Phase Outsourcing Services Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
